Fortive Earnings Call Highlights Growth Amid Tariffs

Fortive ((FTV)) has held its Q1 earnings call. Read on for the main highlights of the call.

Fortive’s latest earnings call struck an overall upbeat tone, balancing solid first-quarter execution with a clear-eyed view of near-term headwinds. Management highlighted broad-based growth, expanding margins, and robust cash generation, while acknowledging tariff pressures, calendar quirks, and a cautious hospital spending backdrop that could mask the true pace of underlying demand.

Revenue Growth Driven by Solid Core Demand

Fortive reported nearly $1.1 billion in first-quarter revenue, representing almost 8% growth on a reported basis. Core revenue rose just over 5%, though management noted this figure was flattered by about 150 basis points of extra selling days, suggesting some of the apparent strength reflects timing rather than a step-change in demand.

Margins and Profitability Continue to Climb

Profitability improved meaningfully despite cost pressures, with adjusted EBITDA rising about 13% to $314 million. Adjusted EBITDA margin expanded roughly 140 basis points to slightly above 29%, underscoring the benefits of productivity initiatives and mix, even as tariffs weighed on gross margins.

EPS Momentum Accelerates

Earnings leverage remained strong, as adjusted EPS reached $0.70 in the quarter, up more than 25% year over year. This marked the third straight quarter of double-digit adjusted EPS growth, reinforcing management’s message that the Fortive Accelerator strategy is driving sustained earnings expansion.

Cash Generation Remains a Strength

Fortive generated $194 million of free cash flow in the first quarter, providing ample financial flexibility. Trailing twelve-month free cash flow conversion was above 100%, giving the company room to fund growth initiatives, repurchases, and strategic deals without straining the balance sheet.

Share Repurchases Boost Per-Share Metrics

Fortive continued to lean into buybacks, deploying about $500 million to repurchase shares in the quarter. Since its spin, the company has returned roughly $1.8 billion via repurchases, retiring around 35 million shares and trimming the diluted share count by just over 10%, amplifying EPS growth for remaining shareholders.

IOS Segment Delivers Steady Expansion

The Intelligent Operating Solutions segment delivered around 8% reported revenue growth and about 5% core growth. Adjusted EBITDA rose roughly 8% to $255 million, with segment EBITDA margin just above 34% and gross margin around 65%, even as tariffs drove about a 150-basis-point gross margin decline.

AHS Segment Posts Robust Margin Gains

Advanced Healthcare Solutions reported $326 million in revenue, up around 8% year over year and about 6% on a core basis. Adjusted EBITDA climbed roughly 18% to $84 million, pushing segment EBITDA margin to just under 26%, about 200 basis points above last year despite continued caution in U.S. hospital capital spending.

Recurring and Software Revenue Outpace the Core

Recurring revenue outgrew the broader business in both major segments, highlighting Fortive’s push toward more resilient, high-margin streams. Management pointed to double-digit services growth at Fluke and strong software momentum, including AI-enabled launches such as Provation Mirror Documentation Assist, as key drivers of this shift.

New Products and Regional Strategies Gain Traction

Commercial momentum remained healthy, with new products such as CertiFiber Max driving pull-through and supporting higher orders at Fluke, where book-to-bill remained above one. Early results from “made-in-region” initiatives in markets such as India and China were also encouraging, improving competitiveness and helping mitigate tariff exposure.

Disciplined Capital Allocation and M&A Readiness

Management reiterated a balanced capital allocation framework prioritizing organic investment, targeted bolt-on M&A, share repurchases, and a modest growing dividend. Two smaller acquisitions currently being integrated are tracking to plan, and the corporate development team has been strengthened to pursue additional deals when valuations and strategic fit align.

Tariff Pressures Hit Gross Margins

Tariffs weighed on profitability at the gross margin line, trimming consolidated adjusted gross margin by about 100 basis points to just above 63%. The impact was especially visible in IOS, where gross margin fell about 150 basis points, and management expects these tariff headwinds to persist into part of the third quarter before fading in the fourth.

Selling Days Inflate Q1 and Cloud Comparisons

Management cautioned that extra selling days created a distortion in the quarter’s growth metrics, providing roughly 150 basis points of core growth benefit overall. The effect was uneven by segment, contributing about 100 basis points in IOS and about 300 basis points in AHS, and will reverse in later quarters as the calendar normalizes.

Hospital Capital Spending Remains a Soft Spot

While AHS delivered solid results, hospital capital equipment budgets in the U.S. remain under pressure, limiting discretionary purchases in parts of the portfolio. Management did note modest sequential improvement, but signaled that a full recovery in hospital spending has yet to materialize, keeping this end market a watch point.

Back-Half Headwinds and Tougher Comparisons

Looking ahead, Fortive expects phasing to turn less favorable, with the fourth quarter facing a $15 million to $20 million revenue headwind from four fewer selling days year over year. Margin expansion is also expected to moderate in the back half as the company laps earlier cost actions and faces tougher comparisons, tempering the pace of improvement.

Leverage Ticks Up on Buybacks

The company’s leverage profile nudged higher as it used a modest amount of commercial paper to help fund repurchases, leaving gross debt at about 2.8 times adjusted EBITDA. Management framed this as a manageable level given strong cash flow, but investors will be watching that additional repurchases do not significantly increase balance sheet risk.

Modeling Uncertainty Around Tariffs and Costs

Although price increases more than offset cost inflation in the quarter, management acknowledged some uncertainty around the timing of tariff mitigation and the lapping of prior cost reductions. These factors could introduce short-term volatility in margins, even as the longer-term framework still calls for steady annual EBITDA margin expansion.

Guidance and Outlook Emphasize Confidence with Caveats

Fortive reaffirmed its full-year 2026 adjusted EPS outlook of $2.90 to $3.00, guiding toward the upper half of the range and targeting core growth of 2% to 3%, also skewing higher. The company expects Q2 and Q3 EPS to run roughly in line with the first quarter’s $0.70, while Q4 will face a $15 million to $20 million revenue drag from fewer selling days, and FX plus M&A should add a modest tailwind to reported growth.

Fortive’s earnings call painted a picture of a company executing well on its strategy, delivering steady growth, expanding margins, and aggressively returning capital, even as tariffs, calendar quirks, and uneven hospital demand complicate the near-term backdrop. For investors, the message was one of cautious optimism: the long-term earnings algorithm remains intact, but near-term results may be choppy as external factors play through.